Submit Deal

AMICUS THERAPEUTICS

Deals Overview

Total Deals2

Valued Deals2

Total Value£ 793 M

Avg. Deal Size£ 397 M

Market Context

Subsidiaries

AMICUS THERAPEUTICS (GENE THERAPY BUSINESS)

1 transaction

Senior Management

Bradley Campbell
President and CEO
John F. Crowley
Chairman and CEO
Simon Harford
CFO

Sort

wilson sonsini goodrich & rosati

HQ - Palo Alto

legal advisors (1)

1 Shared Deal

1 For

£ 441 M

Total Value

troutman pepper

HQ - Atlanta

legal advisors (1)

1 Shared Deal

1 For

£ 441 M

Total Value

skadden arps slate meagher & flom

HQ - New York

legal advisors (1)

1 Shared Deal

1 For

£ 441 M

Total Value

goldman sachs

HQ - New York

financial advisors (1)

1 Shared Deal

1 For

£ 441 M

Total Value

kirkland & ellis

HQ - Chicago, United States

legal advisors (1)

1 Shared Deal

1 Opposite

£ 441 M

Total Value

jefferies & company

HQ - New York

financial advisors (1)

1 Shared Deal

1 Opposite

£ 441 M

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy